PatentsGlobal
Actinium Pharmaceuticals Strengthens Actimab-A Patent Portfolio and Manufacturing Capacity Ahead of Key Clinical Milestones
Actinium Pharmaceuticals has announced significant intellectual property advancements for its Actimab-A targeted radiotherapy program, including the issuance of new U.S. patents covering treatment of solid tumors and acute myeloid leukemia (AML). The company also expanded its manufacturing capabilities by adding a new…
Friday, August 14, 2026